These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1180 related items for PubMed ID: 20675009
21. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T. J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347 [Abstract] [Full Text] [Related]
22. Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. Fang JY, Chen YX, Lu J, Lu R, Yang L, Zhu HY, Gu WQ, Lu LG. Cell Res; 2004 Jun; 14(3):217-26. PubMed ID: 15225415 [Abstract] [Full Text] [Related]
23. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. Deng G, Kakar S, Okudiara K, Choi E, Sleisenger MH, Kim YS. Clin Cancer Res; 2009 Mar 01; 15(5):1519-26. PubMed ID: 19223499 [Abstract] [Full Text] [Related]
24. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia. Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H, Wang YH, Shiseki M, Okada M, Motoji T. Leuk Res; 2011 Apr 01; 35(4):516-21. PubMed ID: 20828818 [Abstract] [Full Text] [Related]
25. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z. Zhonghua Zhong Liu Za Zhi; 2008 Nov 01; 30(11):831-6. PubMed ID: 19173828 [Abstract] [Full Text] [Related]
26. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF, Zhu XJ, Peng G, Dai DQ. Oncol Rep; 2009 Nov 01; 22(5):1221-7. PubMed ID: 19787243 [Abstract] [Full Text] [Related]
27. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan X, Zhou Z, Chen K, Huang A, Li S, Tang N. Oncogene; 2014 May 29; 33(22):2826-35. PubMed ID: 23770846 [Abstract] [Full Text] [Related]
28. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ. Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468 [Abstract] [Full Text] [Related]
29. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. Ishimaru N, Fukuchi M, Hirai A, Chiba Y, Tamura T, Takahashi N, Tabuchi A, Tsuda M, Shiraishi M. Biochem Biophys Res Commun; 2010 Mar 26; 394(1):173-7. PubMed ID: 20188708 [Abstract] [Full Text] [Related]
30. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Magdinier F, Wolffe AP. Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512 [Abstract] [Full Text] [Related]
31. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. Meng CF, Zhu XJ, Peng G, Dai DQ. Cancer Invest; 2010 May 24; 28(4):331-9. PubMed ID: 19857042 [Abstract] [Full Text] [Related]
32. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma. Ge P, Yu X, Wang ZC, Lin J. Asian Pac J Cancer Prev; 2015 May 24; 16(9):4071-5. PubMed ID: 25987089 [Abstract] [Full Text] [Related]
33. Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma. Mizuno Y, Maemura K, Tanaka Y, Hirata A, Futaki S, Hamamoto H, Taniguchi K, Hayashi M, Uchiyama K, Shibata MA, Otsuki Y, Kondo Y. Oncol Rep; 2018 May 24; 39(5):2209-2216. PubMed ID: 29512761 [Abstract] [Full Text] [Related]
34. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T. Mol Carcinog; 2005 Dec 24; 44(4):233-41. PubMed ID: 16163707 [Abstract] [Full Text] [Related]
35. Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. Kato N, Fujimoto H, Yoda A, Oishi I, Matsumura N, Kondo T, Tsukada J, Tanaka Y, Imamura M, Minami Y. Cell Death Differ; 2004 Dec 24; 11 Suppl 2():S153-61. PubMed ID: 15153943 [Abstract] [Full Text] [Related]
36. Histone deacetylation directs DNA methylation in survivin gene silencing. Ma AN, Lu J, Zhou XJ, Wang YX. Biochem Biophys Res Commun; 2011 Jan 07; 404(1):268-72. PubMed ID: 21130077 [Abstract] [Full Text] [Related]
37. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Liu ZY, Wang JY, Liu HH, Ma XM, Wang CL, Zhang XP, Tao YQ, Lu YC, Liao JC, Hu GH. Oncogene; 2013 Mar 07; 32(10):1216-22. PubMed ID: 22614009 [Abstract] [Full Text] [Related]
38. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. Chen YX, Fang JY, Lu J, Qiu DK. Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):312-7. PubMed ID: 15059516 [Abstract] [Full Text] [Related]
39. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. Yang J, Ji W, Qu Y, He L, Zhao X. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan 17; 25(2):64-6. PubMed ID: 21473137 [Abstract] [Full Text] [Related]
40. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D, Kim KT, Scott RJ. BMC Cancer; 2010 Jul 12; 10():366. PubMed ID: 20618997 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]